About Takeda Oncology: Transforming Hope into Action | Takeda Oncology
About Takeda Oncology
We aspire to cure cancer, with inspiration from patients and innovation from everywhere.
At Takeda Oncology, we aspire to cure cancer, with inspiration from patients and innovation from everywhere. Our leadership in oncology spans nearly three decades and includes a range of therapies that have helped to transform the treatment landscape for previously underserved patient populations, in some cases shifting paradigms and becoming standard of care.
We are focused on providing approved medicines for patients in need and advancing a cutting-edge oncology pipeline with the potential to introduce new therapies for people with solid tumors and hematologic cancers.
The conviction that “science is smarter” drives the spirit of Takeda Oncology and the work that we do to ensure that more patients can benefit from – and have access to – life-transforming medicines.
About Takeda Oncology, Transforming Hope into Action
Takeda Oncology, the Global Oncology Business Unit of Takeda Pharmaceutical Company
Takeda Oncology, headquartered in Cambridge, Massachusetts, has hubs in 10 countries; United States, Japan, Germany, Spain & Portugal, France, Italy, the United Kingdom/Ireland and Canada
R&D center is in Cambridge, MA, United States
Manufacturing centers are in five countries: Ireland, Austria, Russia, Japan and United States
